Evidence map›Paper›PMID 29499166›Full record

ArticleAmerican journal of human genetics2018

Mutations in ATP1A1 Cause Dominant Charcot-Marie-Tooth Type 2.

Petra Lassuthova, Adriana P Rebelo, Gianina Ravenscroft, Phillipa J Lamont, Mark R Davis, Fiore Manganelli, Shawna M Feely, Chelsea Bacon, Dana Šafka Brožková, Jana Haberlova and 24 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Mechanism of Rescue of NaInternational journal of molecular sciences · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Association of the RecurrentNeurology. Genetics · 2025
    Article
  7. LncDARS-AS1 Regulates ATP1A1 Stability and Enhances NaAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. ATP1A1-linked diseases require a malfunctioning protein product from one allele.Biochimica et biophysica acta. Molecular cell research · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. De NovoNeurology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 11 institutions in 6 countries.

Petra LassuthovaDNA Laboratory, Department of Pediatric Neurology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague 150 06, Czech Republic.
Adriana P RebeloDr. John T. Macdonald Foundation Department of Human Genetics, John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Gianina RavenscroftCentre for Medical Research, University of Western Australia and Harry Perkins Institute of Medical Research, Nedlands, WA 6009, Australia.
Phillipa J LamontNeurogenetic Unit, Royal Perth Hospital, Perth, WA 6000, Australia.
Mark R DavisNeurogenetics Unit, Department of Diagnostic Genomics, PathWest Laboratory Medicine, QEII Medical Centre, Nedlands, WA 6009, Australia.
Fiore ManganelliDepartment of Neurosciences, Reproductive Sciences and Odontostomathology, Federico II University, Naples 80131, Italy.
Shawna M FeelyDepartment of Neurology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
Chelsea BaconDepartment of Neurology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
Dana Šafka BrožkováDNA Laboratory, Department of Pediatric Neurology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague 150 06, Czech Republic.
Jana HaberlovaDepartment of Pediatric Neurology, 2(nd) Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague 150 06, Czech Republic.
Radim MazanecDepartment of Neurology, 2(nd) Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague 150 06, Czech Republic.
Feifei TaoDr. John T. Macdonald Foundation Department of Human Genetics, John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Cima SaghiraDr. John T. Macdonald Foundation Department of Human Genetics, John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Lisa AbreuDr. John T. Macdonald Foundation Department of Human Genetics, John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Steve CourelDr. John T. Macdonald Foundation Department of Human Genetics, John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Eric PowellDr. John T. Macdonald Foundation Department of Human Genetics, John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL 33136, USA; The Genesis Project foundation, Miami, FL 33136, USA.
Elena BugloDr. John T. Macdonald Foundation Department of Human Genetics, John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Dana M BisDr. John T. Macdonald Foundation Department of Human Genetics, John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Megan F BaxterCentre for Medical Research, University of Western Australia and Harry Perkins Institute of Medical Research, Nedlands, WA 6009, Australia.
Royston W OngCentre for Medical Research, University of Western Australia and Harry Perkins Institute of Medical Research, Nedlands, WA 6009, Australia.
Lorna MarnsNeurogenetics Unit, Department of Diagnostic Genomics, PathWest Laboratory Medicine, QEII Medical Centre, Nedlands, WA 6009, Australia.
Yi-Chung LeeDepartment of Neurology, Taipei Veterans General Hospital, Taipei, Taiwan, Department of Neurology, National Yang-Ming University School of Medicine, 10466 Taipei, Taiwan.
Yunhong BaiDepartment of Neurology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
Daniel G IsomDepartment of Pharmacology, Sylvester Comprehensive Cancer Center, and Center for Computational Sciences, University of Miami, Miami, FL 33136, USA.
René Barro-SoriaDepartment of Physiology and Biophysics, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Ki W ChungDepartment of Biological Science, Kongju National University, Gongju 32588, Korea.
Steven S SchererDepartment of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
H Peter LarssonDepartment of Physiology and Biophysics, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Nigel G LaingCentre for Medical Research, University of Western Australia and Harry Perkins Institute of Medical Research, Nedlands, WA 6009, Australia.
Byung-Ok ChoiDepartment of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Pavel SeemanDNA Laboratory, Department of Pediatric Neurology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague 150 06, Czech Republic.
Michael E ShyDepartment of Neurology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
Lucio SantoroDepartment of Neurosciences, Reproductive Sciences and Odontostomathology, Federico II University, Naples 80131, Italy.
Stephan ZuchnerDr. John T. Macdonald Foundation Department of Human Genetics, John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL 33136, USA. Electronic address: szuchner@med.miami.edu.
University of Miami · USCharles University · CZThe University of Western Australia · AUUniversity of Iowa · USFederico II University Hospital · ITQueen Elizabeth II Medical Centre · AUKongju National University · KRNational Yang Ming Chiao Tung University · TWRoyal Perth Hospital · AUSamsung Medical Center · KRUniversity of Pennsylvania · US

Funding

Uncovering new genes and disease modifiers for ALS and related disordersU54NS092091 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LINDSAY N ALFANO · 2014 to 2026
$19.8M
trainingU54NS065712 · NINDS · WAYNE STATE UNIVERSITY · PI SHY, MICHAEL E. · 2009 to 2023
$19.6M
Polyunsaturated fatty acids as anti-arrhythmic agents.R01HL131461 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BARRO-SORIA, RENE, DYKXHOORN, DEREK MICHAEL · 2016 to 2024
$5.1M
pH regulation of cell surface receptorsR35GM119518 · NIGMS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Daniel Isom · 2016 to 2026
$4.1M
Axonal Injury in Demyelinating DiseaseR01NS043174 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI SCHERER, STEVEN SIMON · 2002 to 2011
$3.1M
Modulation of KCNQ1 channel activityR01GM109762 · NIGMS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI KASS, ROBERT S, LARSSON, HANS PETER · 2014 to 2022
$3.1M
Genomic Studies in Charcot-Marie-Tooth DiseaseR01NS075764 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SHY, MICHAEL E., ZUCHNER, STEPHAN · 2012 to 2016
$3.0M
TISSUE ENGINEERED HUMAN NEUROMUSCULAR JUNCTIONS FOR MODELING AXONAL NEUROPATHYR01NS094388 · NINDS · UNIVERSITY OF WASHINGTON · PI KIM, DEOK-HO · 2017 to 2021
$1.7M
Molecular mechanisms of voltage-gated ion channelsR01NS043259 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI LARSSON, HANS PETER · 2003 to 2006
$1.4M
Molecular Mechanisms of Epilepsy-Causing Mutations in IKM channels.K01NS096778 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BARRO-SORIA, RENE · 2017 to 2019
$590k
NHLBI NIH HHS R01 HL131461NIGMS NIH HHS R01 GM109762NIGMS NIH HHS R35 GM119518NINDS NIH HHS K01 NS096778NINDS NIH HHS R01 NS043174NINDS NIH HHS R01 NS043259NINDS NIH HHS R01 NS075764NINDS NIH HHS R01 NS094388NINDS NIH HHS U54 NS065712NINDS NIH HHS U54 NS092091
6 · The paper itself

Abstract

Although mutations in more than 90 genes are known to cause CMT, the underlying genetic cause of CMT remains unknown in more than 50% of affected individuals. The discovery of additional genes that harbor CMT2-causing mutations increasingly depends on sharing sequence data on a global level. In this way-by combining data from seven countries on four continents-we were able to define mutations in ATP1A1, which encodes the alpha1 subunit of the Na

Indexed as

Genes, DominantAdultAgedAged, 80 and overAmino Acid SequenceCharcot-Marie-Tooth DiseaseChildFamilyFemaleHumansMaleMiddle AgedMutationPedigreeSodium-Potassium-Exchanging ATPaseYoung AdultATP1A1 protein, humanSodium-Potassium-Exchanging ATPaseATP1A1axonal neuropathyCharcot-Marie-ToothCMTgenetic matchmakingMendelian diseaseNa(+),K(+) ATPase

Identifiers

PMID29499166
PMCPMC5985288
OpenAlexW2789419608

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.